Pacific Shuanglin Bio-pharmacy Co., LTD (000403.SZ)
CNY 20.98
(0.33%)
CNY 20.98
(0.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.32 Billion | 2.4 Billion | 1.97 Billion | 1.04 Billion | 915.65 Million | 859.84 Million |
| Cost of Revenue | 1.12 Billion | 1.15 Billion | 1.06 Billion | 537.35 Million | 436.41 Million | 401.32 Million |
| Gross Profit | 1.19 Billion | 1.25 Billion | 908.42 Million | 512.57 Million | 479.24 Million | 458.51 Million |
| Operating Expenses | 503.65 Million | 642.34 Million | 458.83 Million | 289.67 Million | 272.76 Million | 333.96 Million |
| Selling, General and Administrative Expenses | 427.33 Million | 438.73 Million | 273.16 Million | 185.85 Million | 167.19 Million | 197.42 Million |
| Research and Development Expenses | 82.23 Million | 75.36 Million | 35.62 Million | 10.99 Million | 14.73 Million | 28.58 Million |
| Other Expenses | - | 128.24 Million | 150.03 Million | 92.83 Million | 90.84 Million | 107.95 Million |
| Cost and Expenses | 1.63 Billion | 1.79 Billion | 1.52 Billion | 827.03 Million | 709.18 Million | 735.29 Million |
| Operating Income | 695.18 Million | 663.42 Million | 460.42 Million | 220.29 Million | 180.03 Million | 130.98 Million |
| Interest Expense | 8.4 Million | 12.02 Million | 9.98 Million | 19.31 Million | 21.71 Million | 26.03 Million |
| Income Tax Expense | 76.63 Million | 72.7 Million | 66.47 Million | 34.5 Million | 31.16 Million | 22.64 Million |
| Earnings before Tax | 688.1 Million | 660.39 Million | 458.01 Million | 217.19 Million | 189 Million | 97.58 Million |
| Net Income | 612.11 Million | 587.13 Million | 391.06 Million | 185.96 Million | 160.44 Million | 79.98 Million |
| Earnings Per Share Basic | 0.84 | 0.80 | 0.55 | 0.38 | 0.33 | 0.15 |
| Earnings Per Share Diluted | 0.84 | 0.80 | 0.55 | 0.38 | 0.33 | 0.15 |
| Weighted Average Shares Outstanding | 728.63 Million | 730.71 Million | 705.5 Million | 489.21 Million | 489.21 Million | 532.31 Million |
| Weighted Average Shares Outstanding (Diluted) | 728.63 Million | 730.99 Million | 707.16 Million | 490.28 Million | 489.21 Million | 532.31 Million |
| Gross Margin | 0.51 | 0.52 | 0.46 | 0.49 | 0.52 | 0.53 |
| EBIT Margin | 0.36 | 0.33 | 0.32 | 0.27 | 0.29 | 0.21 |
| Profit Margin | 0.26 | 0.24 | 0.20 | 0.18 | 0.18 | 0.09 |
| EBITDA | 841.98 Million | 803.47 Million | 593.76 Million | 283.86 Million | 237.16 Million | 166.51 Million |
| Earnings Before Tax Margin | 0.30 | 0.28 | 0.23 | 0.21 | 0.20 | 0.15 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 695.61 Million | 435.64 Million | 2.32 Billion | 953.9 Million | 665.74 Million | 448.21 Million |
| Cost of Revenue | 363.52 Million | 211.63 Million | 1.12 Billion | 686.74 Million | 323.32 Million | 228.83 Million |
| Gross Profit | 332.08 Million | 224 Million | 1.19 Billion | 267.16 Million | 342.41 Million | 219.37 Million |
| Operating Expenses | 117.25 Million | 94.78 Million | 1.63 Billion | 1.62 Billion | 148.75 Million | 138.74 Million |
| Selling, General and Administrative Expenses | 105.89 Million | 73.9 Million | - | 315.83 Million | 179.67 Million | 63.93 Million |
| Research and Development Expenses | 11.36 Million | 20.86 Million | - | 53.76 Million | 24.38 Million | 15.1 Million |
| Other Expenses | -12.42 Million | -8.16 Million | -1.63 Billion | -1.62 Billion | -532.37 Thousand | -1.77 Million |
| Cost and Expenses | 480.77 Million | 306.42 Million | 1.63 Billion | 1.62 Billion | 472.07 Million | 367.58 Million |
| Operating Income | 214.83 Million | 149.11 Million | 695.13 Million | -667.96 Million | 211.27 Million | 98.19 Million |
| Interest Expense | 3.47 Million | 2 Million | 8.4 Million | 2.2 Million | 2.37 Million | 1.36 Million |
| Income Tax Expense | 24.79 Million | 19.07 Million | 75.99 Million | 31.74 Million | 27.92 Million | 9.62 Million |
| Earnings before Tax | 229.9 Million | 140.94 Million | 688.1 Million | 318.03 Million | 210.73 Million | 96.41 Million |
| Net Income | 205.03 Million | 121.94 Million | 612.11 Million | 285.91 Million | 183.05 Million | 86.76 Million |
| Earnings Per Share Basic | 0.28 | 0.17 | - | 0.39 | 0.25 | 0.12 |
| Earnings Per Share Diluted | 0.28 | 0.17 | - | 0.39 | 0.25 | 0.12 |
| Weighted Average Shares Outstanding | 728.93 Million | 730.66 Million | 732.52 Million | 732.52 Million | 732.52 Million | 730.92 Million |
| Weighted Average Shares Outstanding (Diluted) | 728.93 Million | 730.66 Million | 732.52 Million | 732.52 Million | 732.52 Million | 730.92 Million |
| Gross Margin | 0.48 | 0.51 | 0.51 | 0.28 | 0.51 | 0.49 |
| EBIT Margin | 0.36 | 0.33 | - | -0.70 | 0.32 | 0.22 |
| Profit Margin | 0.29 | 0.28 | 0.26 | 0.30 | 0.27 | 0.19 |
| EBITDA | 249.06 Million | 145.16 Million | - | -667.96 Million | 210.72 Million | 97.93 Million |
| Earnings Before Tax Margin | 0.31 | 0.34 | 0.30 | -0.70 | 0.32 | 0.22 |
RFAI
2754
IRM
0HGV
ORLA
CVPUF